Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The 2006 study by Teichman et al involved administering CJC-1295 DAC to test subjects in weekly or biweekly dosages of between 30 g/kg and 60 g/kg [2]
Maintenance phase: Once the initial phase is completed, the frequency of lipotropic injections may be reduced
The FDA classifies substances intended for administration to humans without approved status as adulterated or misbranded drugs under federal law, meaning commercial products sold as injectable BPC-157 for human use violate federal regulations
Advanced Research Focus BPC-157 research centers on its proposed cytoprotective, angiogenic, and tissue-repair-associated properties observed in preclinical animal models
Presented for research literature review only Wagner B (1989)
US$ 29.81
US$ 25.37
US$ 25.95
US$ 27.32
US$ 20.88
US$ 21.02
US$ 25.53
